Pharmacist discovery spurs recall of extended-release venlafaxine March 7, 2014Bipolar DisorderSchizophrenia & Other Psychotic Disorders
High-yield techniques in brief CBT sessions can promote adherenceFebruary 26, 2014Bipolar DisorderDepressionSchizophrenia & Other Psychotic Disorders
Health care reform may cut behavioral admissionsFebruary 19, 2014Bipolar DisorderPediatricsDepressionAddiction MedicineSchizophrenia & Other Psychotic DisordersBusiness of Medicine
Smoking cessation maintained with varenicline plus CBTJanuary 7, 2014Bipolar DisorderSchizophrenia & Other Psychotic Disorders
Smoking rate among people with mental illness shows negligible declineJanuary 7, 2014Bipolar DisorderSchizophrenia & Other Psychotic Disorders
Antipsychotics boosted CVD events in elderlyDecember 27, 2013Schizophrenia & Other Psychotic DisordersGeriatrics
Cannabis use linked to differences in brain structureDecember 19, 2013Schizophrenia & Other Psychotic Disorders
Second-generation antipsychotics cause modest extrapyramidal symptomsNovember 8, 2013Bipolar DisorderSchizophrenia & Other Psychotic Disorders
Johnson & Johnson agrees to pay billions in drug misbranding settlementNovember 5, 2013Alzheimer's & CognitionSchizophrenia & Other Psychotic DisordersPediatricsGeriatrics
ABIM’s Choosing Wisely campaign advises against overprescribing antipsychoticsOctober 10, 2013Schizophrenia & Other Psychotic DisordersBusiness of Medicine
First-episode schizophrenia patients often have hyperprolactinemiaOctober 8, 2013Schizophrenia & Other Psychotic Disorders
Psychiatrists get low marks in assessing adherenceAugust 16, 2013Schizophrenia & Other Psychotic Disorders
CRTC1 polymorphisms affect BMI, novel study findsAugust 7, 2013Bipolar DisorderDepressionSchizophrenia & Other Psychotic Disorders
Novel intervention improves outcomes in homeless schizophrenia patientsAugust 2, 2013Somatic DisordersSchizophrenia & Other Psychotic Disorders
